37271037|t|Nicotinamide mononucleotide improves the Alzheimer's disease by regulating intestinal microbiota.
37271037|a|Alzheimer's disease (AD) is the most common progressive neurodegenerative disease, and the intestinal flora and its metabolites play an important role in the amelioration of central nervous system (CNS) disorders such as AD through a bidirectional interaction between the gut-brain axis (GBA). Nicotinamide mononucleotide (NMN), one of the precursors for nicotinamide adenine dinucleotide (NAD+) synthesis, reduces the brain features of AD, including neuroinflammation, mitochondrial abnormalities, synaptic dysfunction, and cognitive impairment. However, the impact of NMN on the gut flora of AD is still unknown. In the current study, we investigated the relationship between gut flora and NMN treatment in APP/PS1 transgenic (AD) mice through the 16S ribosomal RNA (rRNA) high-throughput sequencing analysis of mouse feces after being treated with NMN for 16 weeks. The results show that the NMN significantly changed the intestinal microbial community composition in AD mice. The NMN also increased the relative abundance of short-chain fatty acids (SCFAs)-producing bacteria such as Lactobacillus and Bacteroides at the genus level by protecting intestinal health and improving AD. The overall results suggest novel therapeutic strategies for treating AD and highlight the critical role of gut microbiota in AD pathology, and layout the further research.
37271037	0	27	Nicotinamide mononucleotide	Chemical	MESH:D009537
37271037	41	60	Alzheimer's disease	Disease	MESH:D000544
37271037	98	117	Alzheimer's disease	Disease	MESH:D000544
37271037	119	121	AD	Disease	MESH:D000544
37271037	154	179	neurodegenerative disease	Disease	MESH:D019636
37271037	272	310	central nervous system (CNS) disorders	Disease	MESH:D002493
37271037	319	321	AD	Disease	MESH:D000544
37271037	392	419	Nicotinamide mononucleotide	Chemical	MESH:D009537
37271037	421	424	NMN	Chemical	MESH:D009537
37271037	453	486	nicotinamide adenine dinucleotide	Chemical	MESH:D009243
37271037	488	492	NAD+	Chemical	MESH:D009243
37271037	535	537	AD	Disease	MESH:D000544
37271037	549	566	neuroinflammation	Disease	MESH:D000090862
37271037	568	595	mitochondrial abnormalities	Disease	MESH:D028361
37271037	597	617	synaptic dysfunction	Disease	MESH:C536122
37271037	623	643	cognitive impairment	Disease	MESH:D003072
37271037	668	671	NMN	Chemical	MESH:D009537
37271037	692	694	AD	Disease	MESH:D000544
37271037	790	793	NMN	Chemical	MESH:D009537
37271037	811	814	PS1	Gene	19164
37271037	827	829	AD	Disease	MESH:D000544
37271037	831	835	mice	Species	10090
37271037	912	917	mouse	Species	10090
37271037	949	952	NMN	Chemical	MESH:D009537
37271037	993	996	NMN	Chemical	MESH:D009537
37271037	1069	1071	AD	Disease	MESH:D000544
37271037	1072	1076	mice	Species	10090
37271037	1082	1085	NMN	Chemical	MESH:D009537
37271037	1127	1150	short-chain fatty acids	Chemical	MESH:D005232
37271037	1152	1157	SCFAs	Chemical	MESH:D005232
37271037	1186	1199	Lactobacillus	Species	1578
37271037	1281	1283	AD	Disease	MESH:D000544
37271037	1355	1357	AD	Disease	MESH:D000544
37271037	1411	1413	AD	Disease	MESH:D000544
37271037	Negative_Correlation	MESH:D009537	MESH:D000544
37271037	Negative_Correlation	MESH:D009243	MESH:D028361
37271037	Negative_Correlation	MESH:D009537	MESH:D028361
37271037	Negative_Correlation	MESH:D009243	MESH:C536122
37271037	Positive_Correlation	MESH:D005232	MESH:D009537
37271037	Negative_Correlation	MESH:D009537	MESH:C536122
37271037	Negative_Correlation	MESH:D009243	MESH:D003072
37271037	Positive_Correlation	MESH:D009243	MESH:D009537
37271037	Negative_Correlation	MESH:D009243	MESH:D000090862
37271037	Association	MESH:D005232	MESH:D000544
37271037	Negative_Correlation	MESH:D009537	MESH:D003072
37271037	Negative_Correlation	MESH:D009243	MESH:D000544
37271037	Negative_Correlation	MESH:D009537	MESH:D000090862

